Incidence and prevalence of adverse drug reactions

被引:0
|
作者
Haramburu, F
Pouyanne, P
Imbs, JL
Blayac, JP
Bégaud, B
机构
[1] Univ Victor Segalen, CHU, Dept Pharmacol, Ctr Pharmacovigilance, Bordeaux, France
[2] Hop Univ Strasbourg, Ctr Pharmacovigilance, Strasbourg, France
[3] Hop St Charles, Assoc Francaise, Ctr Reg Pharmacovigilance, Montpellier, France
来源
PRESSE MEDICALE | 2000年 / 29卷 / 02期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Fundamental data: Estimation of incidence and prevalence rates of adverse drug reactions are necessary to assess the consequences and impact of these effects in a population. Hospital studies: During the last 20 years, several studies conducted in one or more departments of a single hospital have found incidence of hospitalizations induced by adverse drug reactions between 2 and 8% Three meta- analyses confirm these reports with incidence varying from 4.4 to 5.8% in different countries and from 5.2 to 8.2% and from 2.37 to 3.6% in the United States and Australia respectively Two recent studies conducted by the French pharmacovigilance regional centers on a representative sample of medical departments in public hospitals found a prevalence of adverse drug reactions between 4.2 and 22.1% (according to the type of department and hospital) and a hospitalization incidence due to adverse drug reaction between 2.37 and 4.01%. Community studies: In community medicine, few data are available. in general medicine, the incidence would be 1.99 adverse effects per general practitioner per day. The number of serious adverse drug reactions has been estimated at 0.01 per general practitioner per day. These numbers show the magnitude of adverse drug reactions in terms of morbidity and mortality.
引用
收藏
页码:111 / 114
页数:4
相关论文
共 50 条
  • [21] Prospective cohort study of adverse drug reactions on all admissions to internal medicine: Prevalence, incidence and risk factors
    Adedapo, Aduragbenro D. A.
    Adedeji, Waheed
    Adedapo, IfetiOluwanimi A.
    Adedapo, Kayode S.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 356 - 357
  • [22] PREVALENCE AND PREDICTORS OF ADVERSE DRUG REACTIONS IN OLDER HYPERTENSIVE ADULTS
    Turrin, Giada
    Coscarelli, Antonio
    D'andria, Maria Flora
    Tortu, Virginia
    Giuliani, Evelina
    Ungar, Andrea
    Rivasi, Giulia
    JOURNAL OF HYPERTENSION, 2021, 39 : E256 - E256
  • [23] Estimation of the prevalence of adverse drug reactions from social media
    Thin Nguyen
    Larsen, Mark E.
    O'Dea, Bridianne
    Phung, Dinh
    Venkatesh, Svetha
    Christensen, Helen
    INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS, 2017, 102 : 130 - 137
  • [24] Adverse Drug Reactions in an Oncological Population: Prevalence, Predictability, and Preventability
    Lavan, Amanda Hanora
    O'Mahony, Deirdre
    Buckley, Mary
    O'Mahony, Denis
    Gallagher, Paul
    ONCOLOGIST, 2019, 24 (09): : E968 - E977
  • [25] Prevalence, characteristics, and reporting of adverse drug reactions in an Australian hospital: a retrospective review of hospital admissions due to adverse drug reactions
    Li, Raymond
    Curtis, Kate
    Zaidi, Syed Tabish Razi
    Van, Connie
    Thomson, Amy
    Castelino, Ronald
    EXPERT OPINION ON DRUG SAFETY, 2021, 20 (10) : 1267 - 1274
  • [26] Study of Incidence and Severity of Adverse Drug Reactions and Adverse Drug Reaction monitoring in Govt General Hospital, Guntur"
    Bano, Zaheda
    INDIAN JOURNAL OF PHARMACOLOGY, 2013, 45 : S56 - S56
  • [27] Adverse drug reactions in a department of systemic diseases-oriented internal medicine: prevalence, incidence, direct costs and avoidability
    R. Lagnaoui
    N. Moore
    J. Fach
    M. Longy-Boursier
    B. Bégaud
    European Journal of Clinical Pharmacology, 2000, 56 : 181 - 186
  • [28] Adverse drug reactions in a department of systemic diseases-oriented internal medicine:: prevalence, incidence, direct costs and avoidability
    Lagnaoui, R
    Moore, N
    Fach, J
    Longy-Boursier, M
    Bégaud, B
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 56 (02) : 181 - 186
  • [29] A study of incidence and clinical characteristics of adverse drug reactions in hospitalized patients
    Esteban Jimenez, Oscar
    Navarro Peman, Cristina
    Gonzalez Rubio, Francisca
    Lanuza Gimenez, Francisco Javier
    Montesa Lou, Cristina
    REVISTA ESPANOLA DE SALUD PUBLICA, 2017, 91
  • [30] Incidence of Adverse Drug Reactions in a Post Emergency Department of an University Hospital
    Castel, M.
    Durrieu, G.
    Vernet, J.
    Tubery, M.
    Ecoflier, M.
    Montastruc, I. L.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2010, 24 : 73 - 73